drugset / Trial / NCT00002988
Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of irinotecan plus carmustine in treating patients who have recurrent primary malignant glioma.
Timeline
- Start
- 1997-04
- Primary completion
- 2000-11
- Completion
- 2000-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | Intravenous |
| Subject | carmustine | Small molecule | — | Intravenous |